GE HealthCare Is Weighing Strategic Options For Patient Care Unit As Its Chief Leaves

CEO Peter Arduini says the leadership change will not delay the review, and the unit's third-quarter revenue grew 8.8% organically.

Share
GE HealthCare Is Weighing Strategic Options For Patient Care Unit As Its Chief Leaves

GE HealthCare, which makes medical imaging equipment, patient monitors and diagnostic imaging agents, is evaluating strategic options for its Patient Care Solutions business, CEO Peter Arduini said on the company's third-quarter earnings call Wednesday. He disclosed on the same call that the unit's leader, Jeannette Bankes, is leaving to become CEO of another publicly traded company.

A new chief, and a review that stays on track

Arduini said Bankes is departing for a CEO role at a non-competitive publicly traded company. Neil Sandy, currently head of product strategy and management for the unit, will become its CEO. Arduini cited Sandy's more than 30 years of industry experience.

A BMO Capital Markets analyst asked whether the change could delay a decision on the review. "The short answer is no, it does not," Arduini replied, saying Sandy "knows this business extremely well" and has been heavily involved in leading much of the strategic assessment.

Of Bankes, Arduini said: "Public company CEO jobs don't come around that often." He added that the company was happy for her because the new job is not competitive with GE HealthCare.

A unit that bounced back in the quarter

Patient Care Solutions grew organic revenue 8.8% from a year earlier, CFO Bill Grogan said, on better product fulfillment in monitoring and maternal infant care. Segment margin expanded 480 basis points, or 4.8 percentage points, on higher volume and cost productivity.

The unit had struggled earlier in the year, when coverage of the second quarter pointed to fulfillment problems. Arduini said supplier issues were the bigger challenge in the first and second quarters, and that the team has since shifted from a monthly and weekly management rhythm to a weekly and daily one. Some monitoring installations also slipped into the second half, he said, and that is playing out as expected.

Grogan cautioned that the fourth quarter of 2025 included about $45 million of revenue from the release of a product hold, which will mute the unit's growth in the coming quarter. He said that comparison, not a market slowdown, explains the implied fourth-quarter company growth of 3% to 4%.

Raised outlook and a stock move

Company revenue of $5.5 billion rose 6.2% organically, and adjusted earnings per share of $1.34 rose 25.1%. GE HealthCare now expects full-year organic revenue growth of about 4%, adjusted earnings of $4.95 to $5.05 per share and free cash flow above $1.6 billion.

Shares were at $75.19, up about 6% from the prior close, in Wednesday trading, giving the company a market value of $32.1 billion.

Arduini pointed to the Radiological Society of North America meeting in Chicago as a pivotal window for new products, though he gave no date for any decision on the Patient Care unit.

Sources

More on GE HealthCare

All GE HealthCare (GEHC) coverage →